What's happening
National Academies Welcome Inaugural Cohort of Biotechnology Regulatory Fellowship Fellows
News Release
Ten fellows will join the National Academies’ new Biotechnology Regulatory Fellowship Program, launched recently to engage early-career professionals in developing the evidence basis needed to meet future regulatory challenges presented by novel products of biotechnology. These fellows will identify possible regulatory frameworks for the cutting-edge products expected to emerge over the next several decades and provide government agencies with options for effective regulation.
Protecting Human Health through Biotechnology Breakthroughs and Platforms
Perspectives
On November 15, 2020, after 4 months in large-scale Phase 3 clinical testing, Moderna received resounding proof that its new class of medicines based on messenger RNA encased in lipid nanoparticles could be safely deployed as a highly effective vaccine to combat the COVID-19 pandemic.
- Report Lays Out Road Map to Transform Understanding of RNA and Invest in RNA Science and Biotechnology Mar 21, 2024 News Release
- Biomedical Journal Editors Announce New Practices for Using Race, Ethnicity, and Ancestry Descriptors in Genomics Research, Following Recommendations from 2023 National Academies Report Mar 12, 2024 Feature Story
- NAS and NAM Presidents, Other Experts Urge Biden Administration to Reinstate Presidential Bioethics Commission Mar 2, 2022 News Release
- Cato T. Laurencin Receives Prestigious Spingarn Medal from NAACP Jul 6, 2021 News Release
- On Human Gene Editing: International Summit Statement Dec 3, 2015 News Release
Discover
Events
Right Now & Next Up
Stay in the loop with can’t-miss sessions, live events, and activities happening over the next two days.
NAS Building Guided Tours Available!
Participate in a one-hour guided tour of the historic National Academy of Sciences building, highlighting its distinctive architecture, renowned artwork, and the intersection of art, science, and culture.